MicroPort NeuroScientific Corporation announced that its board approved the grant of 550,000 share options to two employees under the company’s Share Scheme adopted on 12 July 2023. The grant was made on 1 April 2026.
The options carry an exercise price of HK$10.97 per share, equal to the highest of: 1) the 1 April 2026 closing price of HK$10.97, 2) the five-day average closing price of HK$10.574, and 3) the share’s nominal value of US$0.00002.
Each option entitles the holder to subscribe for one ordinary share. The options are valid for ten years and vest evenly over five years, with 20% vesting on each anniversary of the grant date. No additional performance targets apply, but a clawback mechanism—covering option lapse upon employment cessation and potential cancellation at the Board’s discretion—remains in force.
Post-grant, 49.72 million shares remain available for future awards under the Share Scheme, of which 5.83 million shares are reserved for service providers.
The company confirms that: • No financial assistance was provided to the grantees for the purchase of shares. • Neither grantee is a director, chief executive, substantial shareholder, related entity participant or service provider as defined by the Listing Rules. • Neither grantee’s cumulative awards exceed the 1% individual limit set by the Listing Rules.
MicroPort NeuroScientific states the option grant aligns with its objective of incentivising key talent to support the Group’s long-term development and operational success.
Comments